4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-23-049778
Chief Medical Officer sold 6,918 shares at an average $3.57 ($24,730)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2023-09-25 | Sale | −3,678 | $3.57 | $13,130 | 375,044 | D |
| Karlin Dan Chief Medical Officer | 2023-09-25 | Sale | −3,240 | $3.58 | $11,599 | 371,804 | D |
| Open-market sales · 6,918 sh · avg $3.57 · $24,730 | |||||||
Loading xslF345X05/ownership.xml…